InvestorsObserver
×
News Home

Does the Market Like PDS Biotechnology Corp (PDSB) Stock After it Is Up 53.62% in a Week?

Monday, June 29, 2020 09:57 AM | InvestorsObserver Analysts

Mentioned in this article

Does the Market Like PDS Biotechnology Corp (PDSB) Stock After it Is Up 53.62% in a Week?

Overall market sentiment has been high on PDS Biotechnology Corp (PDSB) stock lately. PDSB receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
PDS Biotechnology Corp has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PDSB!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.

InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.

For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With PDSB Stock Today?

PDS Biotechnology Corp (PDSB) stock is up 30.59% while the S&P 500 is down -2.42% as of 9:55 AM on Monday, Jun 29. PDSB is up $0.50 from the previous closing price of $1.62 on volume of 651,370 shares. Over the past year the S&P 500 has gained 1.51% while PDSB is down -64.90%. PDSB lost -$3.02 per share in the over the last 12 months.

To see the top 5 stocks in the Biotechnology industry click here.

More About PDS Biotechnology Corp

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App